The Enlarged Board of Appeal of the European Patent Office solved this by allowing claims to protect the "Use of substance X in the manufacture of a medicament for the treatment of condition Y".
欧洲专利局上诉委员会通过允许权利要求保护“在制造治疗情况Y的医药中使用物质X”而解决了这个问题。